US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Abstract, Snapshot, Market Analysis & Market Definition: Global ADME Toxicology Testing Market The global ADME toxicology testing market size was valued at USD 4.33 billion in 2017 and is expected to register a CAGR of 11.4% over the forecast period. A rising number of drug molecules have been failing in the final stages of clinical trials, resulting in loss of valuable time and investments in drug discovery and development. This has resulted in increased investments in the discovery of newer technologies for toxicity testing, which is set to boost the market in the coming decade. ADME toxicology testing is mainly used for conducting various genetic, chemical, and pharmacological tests that aid the drug discovery process, starting from drug design to drug trails and other drug interactions. This process involves control software, various devices to handle liquids, and other detectors that help rapidly identify active compounds, genetic interactions, and other biomolecular interactions. However, most of these techniques need skilled expertise and software that can handle and store multiple sets of data at a rapid pace. This could limit market growth to an extent. ADME toxicology testing is now done throughout drug design and development to prevent any late-stage failure and to ensure systematic evaluation to prevent potential loss of a molecule or investment. Most companies follow GLP and non-GLP testing procedures to meet regulatory standards. Regulatory bodies are being pushed to establish tighter quality control standards to achieve integrity and accuracy of obtained and stored data. However, lack of efficient software to handle automated robotic arms and liquid handling systems is likely to affect the market’s growth. Regulatory changes from governing bodies such as U.S. FDA are likely to impact the market and the direction of innovations carried out. For instance, some departments of the FDA have asked companies to conduct ADME toxicology testing on animals experiencing the same disease state as humans, so as to draw a clear line between real-time results of close situation and of results from normal animals. Market Segmentation, Outlook & Viewpoint: Global ADME Toxicology Testing Market Technology Market Segmentation & Outlook (Revenue, USD Billion, 2014 - 2025) Cell Culture High Throughput Molecular Imaging OMICS Technology Application Market Segmentation & Outlook (Revenue, USD Billion, 2014 - 2025) Systemic Toxicity Renal Toxicity Hepatotoxicity Neurotoxicity Others Method Market Segmentation & Outlook (Revenue, USD Billion, 2014 - 2025) Cellular Assay Biochemical Assay In Silica Ex-vivo Key Players, Recent Developments & Regional Insights: Global ADME Toxicology Testing Market ADME toxicology testing is carried out for various human reactions to drug molecules. A few examples are systemic toxicity, hepatic toxicity, renal toxicity, and neurotoxicity. In 2017, systemic toxicity emerged as the leading revenue-generating segment owing to surge in toxicity studies on the circulatory system. It is by far the most potent cause of toxic reactions in the human body. Systemic toxicity held a market share of about 70.0% in 2017 and is expected to retain its dominance throughout the forecast period. Since systemic circulation of the molecule is the most preferred method of drug distribution, it is also one of the major causes of toxic reactions, which may trigger multiple organs to fail. As a result, this segment has enjoyed a significant share in the market. Renal toxicity and hepatotoxicity are other major applications slated to witness steady growth. Active research and studies are being carried out in these fields, which is expected to drive both the segments to register a growth rate higher than that of systemic toxicity. Regional Insights North America accounted for the largest share of more than 45.0% in 2017, with throughput/content screening emerging as a major contributor. This is owing to ongoing technological advancements in the field, particularly in U.S. Drug discovery techniques using cell cultures has especially gained popularity among companies competing to reach the market with a new drug molecule. Asia Pacific is set to grow at a significant pace over the forecast years due to increased efforts for new pharmaceutical molecules and adoption of newer technologies to improve the standard of medicine being supplied. China and Japan are key countries contributing to market growth. ADME Toxicology Testing Market Share Insights Some of the key players in this market are Accelrys Inc.; Agilent Technologies, Inc.; Albany Molecular Research Inc.; Beckman Coulter Inc.; Catalent Inc.; Charles River Laboratories International Inc.; AbbVie; Actelion Pharmaceuticals; Amgen; Biocon; BioMarin; Boehringer Ingelheim; Bristol-Myers Squibb; Cipla; and CymaBay Therapeutics. Fierce competition between manufacturers to commercialize novel molecules is pushing companies to adopt accurate toxicity testing techniques that would effectively reduce drug development costs and save time on failed drugs. Key Insights Covered: Global ADME Toxicology Testing Market 1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of ADME Toxicology Testing industry. 2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of ADME Toxicology Testing industry. 3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of ADME Toxicology Testing industry. 4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of ADME Toxicology Testing industry. 5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of ADME Toxicology Testing industry. Research Methodology: Global ADME Toxicology Testing Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other
Table of Contents Chapter 1 Research Methodology 1.1 Information Procurement 1.2 Data AnalysisChapter 2 Executive Summary 2.1 Market SnapshotChapter 3 Market Variables, Trends & Scope 3.1 Market segmentation & scope 3.1.1 Market driver Analysis 184.108.40.206 High rate of late stage drug failure 220.127.116.11 Increasing need for novel drug molecules 18.104.22.168 Technological advancements 3.1.2 Market restraint analysis 22.214.171.124 Decreasing investments in drug development 3.2 Penetration & growth prospect mapping 3.3 ADME toxicology testing - SWOT Analysis, By Factor (polit | read more...